Posts Tagged ‘adverse events’

The Department of Health and Human Services (HHS) Office of Inspector General (OIG) submitted its semiannual report to Congress, reporting an expected $2.4 billion in recoveries the first half of the fiscal year. Recoveries were made from providers, drug companies, other agencies, and even four states.

Read more »

Fifteen percent of hospitalized Medicare beneficiaries in two selected counties experienced an adverse event during their hospital stays, the Office of the Inspector General (OIG) said in a Dec. 19, 2008 report. Read more »

The U.S. Food and Drug Administration (FDA) seized 11 lots of contaminated heparin—a blood thinner drug—from Celsus Laboratories Inc. on Nov. 6, according to an FDA news release.

The 11 lots consisted of five lots of Heparin Sodium Active Pharmaceutical Ingredient (API) and six lots of Heparin Lithium. These products were manufactured in China and found to be contaminated with over-sulfated chondroitin sulfate (OSCS)—a substance that mimics heparin’s anticoagulant activity. Read more »